Journals & Books:
Access Bentham Online:    
Marketing Opportunities:
Authors:

Current Signal Transduction Therapy

ISSN: 1574-3624 - Volume 3, 3 Issues, 2008


Aims & Scope

In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.

The aim of this journal is to publish timely in-depth reviews as well as original papers in the field of signal transduction therapy. Thematic issues will also be published to cover selected areas of signal transduction therapy. Coverage of the field will include genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases.

Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.



Indexed in
Chemical Abstracts, Science Citation Index Expanded, Journal Citation Reports/Science Edition, Index to Scientific Reviews, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, EMBASE, Google, Google Scholar

You may also be interested in:

Current Clinical Pharmacology
Current Neuropharmacology
Current Cancer Drug Targets
Current Drug Target
Current Molecular Medicine

Copyright © Bentham Science Publishers Ltd    Terms and Conditions
toptop